Clinical Trial Update: Converting HR+ Breast Cancer Into an Individualized Vaccine [Phase 2]

View source ↗

Summary

Phase 2 trial update exploring an individualized vaccine approach for hormone receptor-positive breast cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING